Valacyclovir Monotherapy in Pain Management of Acute Periapical Abscesses After Emergency Chamber Opening
Conditions: Acute Apical Abscess Interventions: Drug: Valacyclovir 500 MG; Drug: Naproxen Sodium 550mg Sponsors: Dow University of Health Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Conditions: PASC Post Acute Sequelae of COVID 19; Long COVID Interventions: Drug: 1500 Valacyclovir 200 Celecoxib; Drug: 750 Valacyclovir 200 Celecoxib; Drug: Placebo Sponsors: Bateman Horne Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
The Efficacy of Systemic Valacyclovir (Valtrex) on Periodontitis
Condition: Severe Periodontitis Interventions: Drug: Valacyclovir group; Other: Control group Sponsor: University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 3, 2023 Category: Research Source Type: clinical trials
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-na ïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
Condition: Leukemia Interventions: Drug: Pirtobrutinib; Drug: Obinutuzumab; Drug: Venetoclax; Drug: Valacyclovir; Drug: Allopurinol Sponsors: M.D. Anderson Cancer Center; Loxo Oncology, Inc.; The Leukemia and Lymphoma Society Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2022 Category: Research Source Type: clinical trials
